Gayatri BioOrganics (BSE 524564)₹8.08+0.62%Commodity Chemicals
In the Jun 2026 quarter (standalone), Gayatri BioOrganics reported sales of ₹2.35 Cr and net profit of −₹0.09 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹1.10 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.35 |
| Expenses | 0.08 | 0.11 | 0.19 | 0.16 | 0.12 | 0.09 | 0.11 | 0.19 | 0.13 | 0.14 | 0.33 | 2.34 |
| Operating Profit | −0.08 | −0.09 | −0.19 | −0.14 | −0.10 | −0.07 | −0.09 | −0.17 | −0.11 | −0.12 | −0.33 | 0.02 |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | 0.4% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 | 0.07 | 0.06 | 0.07 | 0.08 | 0.08 | 0.09 | 0.10 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.12 | −0.15 | −0.24 | −0.22 | −0.19 | −0.17 | −0.18 | −0.27 | −0.22 | −0.23 | −0.43 | −0.11 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.10 | −0.13 | −0.22 | −0.20 | −0.17 | −0.15 | −0.16 | −0.25 | −0.20 | −0.21 | −0.41 | −0.09 |
| EPS (Rs) | −0.02 | −0.03 | −0.04 | −0.04 | −0.03 | −0.03 | −0.03 | −0.04 | −0.04 | −0.04 | −0.06 | −0.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 137 | 79.41 | 174 | 156 | 0.00 | 0.00 | 0.00 | 1.68 | 0.00 | 0.00 | 0.00 | 2.35 |
| Expenses | 162 | 129 | 198 | 159 | 0.62 | 0.51 | 0.51 | 2.45 | 0.54 | 0.46 | 0.76 | 2.94 |
| Operating Profit | −24.80 | −49.22 | −23.87 | −3.60 | −0.60 | −0.51 | −0.49 | −0.76 | −0.54 | −0.44 | −0.76 | −0.54 |
| OPM % | −18.1% | −62.0% | −13.7% | −2.3% | — | — | — | −46.1% | — | — | — | −23.0% |
| Other Income | 0.97 | −16.57 | 11.89 | 2.11 | 85.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 12.73 | 11.56 | 0.18 | 4.70 | 0.00 | 0.00 | 0.00 | 0.02 | 0.14 | 0.27 | 0.35 | 0.35 |
| Depreciation | 2.12 | 5.35 | 6.95 | 9.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −38.73 | −82.78 | −19.16 | −15.52 | 84.57 | −0.51 | −0.51 | −0.81 | −0.69 | −0.74 | −1.12 | −0.99 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 26.2% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 1.01 | −17.06 | 0.00 | 0.00 | 85.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −38.62 | −82.40 | −19.10 | −15.48 | 84.21 | −0.49 | −0.49 | −1.00 | −0.67 | −0.72 | −1.10 | −0.91 |
| EPS (Rs) | −6.28 | −10.52 | −2.44 | −1.98 | 10.74 | −0.07 | −0.07 | −0.14 | −0.10 | −0.10 | −0.15 | −0.16 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50.82 | 61.60 | 78.52 | 78.59 | 78.59 | 78.72 | 78.72 | 78.73 | 78.74 | 78.74 | 78.74 | 78.72 |
| Reserves | −40.92 | −79.72 | −160 | −182 | −196 | −111 | −112 | −112 | −113 | −114 | −115 | −116 |
| Borrowings | 88.25 | 116 | 35.19 | 35.17 | 35.16 | 35.21 | 35.22 | 35.19 | 35.77 | 36.46 | 37.00 | 37.72 |
| Other Liabilities | 44.15 | 44.21 | 151 | 214 | 228 | 0.47 | 0.48 | 0.60 | 0.44 | 0.38 | 0.67 | 1.10 |
| Total Liabilities | 142 | 142 | 105 | 146 | 145 | 3.08 | 2.61 | 2.23 | 1.61 | 1.58 | 1.66 | 1.73 |
| Fixed Assets | 47.39 | 45.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 5.79 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 89.12 | 89.95 | 105 | 146 | 145 | 3.08 | 2.61 | 2.23 | 1.61 | 1.58 | 1.66 | 1.73 |
| Inventories | 36.06 | 36.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 44.42 | 43.78 | 1.52 | 1.52 | 0.53 | 0.49 | 0.49 | 0.49 | 0.26 | 0.26 | 0.26 | 0.26 |
| Cash & equivalents | 2.03 | 1.97 | 0.00 | 0.00 | 0.24 | 0.97 | 0.45 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
| Total Assets | 142 | 142 | 105 | 146 | 145 | 3.08 | 2.61 | 2.23 | 1.61 | 1.58 | 1.66 | 1.73 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.06 | −26.42 | −13.73 | −2.61 | −0.58 | 84.41 | −0.51 | −0.39 | −0.55 | −0.68 | −0.54 | −0.73 |
| Cash from investing activity | −7.09 | −1.41 | −0.74 | 2.61 | 0.81 | −83.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing activity | 4.46 | 27.95 | 15.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | 0.69 | 0.53 | 0.72 |
| Net cash flow | −1.54 | 0.11 | 1.01 | 0.00 | 0.22 | 0.72 | −0.51 | −0.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 6.10 | 1.68 | 2.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −5.03 | −28.14 | −16.05 | −2.61 | −0.58 | 84.41 | −0.51 | −0.39 | −0.55 | −0.68 | −0.54 | −0.73 |
| CFO / OP % | 7.0% | 107.0% | 28.0% | 11.0% | 16.0% | −13,867.0% | 104.1% | 80.1% | 73.0% | 130.0% | 122.0% | 99.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 64 | 117 | 8 | 4 | 2 | — | — | 56 | — | — | — |
| Inventory days | 64 | 99 | 0 | 0 | 0 | — | — | 0 | — | — | — |
| Days payable | 58 | 78 | — | — | — | — | — | — | — | — | — |
| Cash conversion cycle | 66 | 134 | 6 | 2 | 0 | — | — | 54 | — | — | — |
| Working capital days | 6 | −102 | −365 | −211 | −270 | — | — | −7,048 | — | — | — |
| ROCE % | 14.8% | −27.2% | −209.8% | — | — | −20.9% | −26.5% | −54.5% | −44.5% | −40.7% | −91.9% |
For the Jun 2026 quarter, Gayatri BioOrganics reported sales of ₹2.35 Cr and net profit of −₹0.09 Cr. The operating margin was 0.4%.
Gayatri BioOrganics' sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹2.35 Cr.
Net profit for the year to Mar 2026 was −₹1.10 Cr, and −₹0.91 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.16.
Gayatri BioOrganics reported borrowings of ₹37.72 Cr at Mar 2026, against cash and equivalents of ₹0.03 Cr.
Cash from operations was −₹0.73 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.73 Cr.